{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:26:30Z","timestamp":1780500390491,"version":"3.54.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Parkinson\u2019s disease is an age-related neurological disorder, and the pathology of the disease is linked to different types of aggregates of \u03b1-synuclein or alpha-synuclein (aS), which is an intrinsically disordered protein. The C-terminal domain (residues 96\u2013140) of the protein is highly fluctuating and possesses random\/disordered coil conformation. Thus, the region plays a significant role in the protein\u2019s solubility and stability by an interaction with other parts of the protein. In the current investigation, we examined the structure and aggregation behavior of two artificial single point mutations at a C-terminal residue at position 129 that represent a serine residue in the wild-type human aS (wt aS). Circular Dichroism (CD) and Raman spectroscopy were performed to analyse the secondary structure of the mutated proteins and compare it to the wt aS. Thioflavin T assay and atomic force microscopy imaging helped in understanding the aggregation kinetics and type of aggregates formed. Finally, the cytotoxicity assay gave an idea about the toxicity of the aggregates formed at different stages of incubation due to mutations. Compared to wt aS, the mutants S129A and S129W imparted structural stability and showed enhanced propensity toward the \u03b1-helical secondary structure. CD analysis showed proclivity of the mutant proteins toward \u03b1-helical conformation. The enhancement of \u03b1-helical propensity lengthened the lag phase of fibril formation. The growth rate of \u03b2-sheet-rich fibrillation was also reduced. Cytotoxicity tests on SH-SY5Y neuronal cell lines established that the S129A and S129W mutants and their aggregates were potentially less toxic than wt aS. The average survivability rate was \u223c40% for cells treated with oligomers (presumably formed after 24\u00a0h of incubation of the freshly prepared monomeric protein solution) produced from wt aS and \u223c80% for cells treated with oligomers obtained from mutant proteins. The relative structural stability with \u03b1-helical propensity of the mutants could be a plausible reason for their slow rate of oligomerization and fibrillation, and this was also the possible reason for reduced toxicity to neuronal cells.<\/jats:p>","DOI":"10.3389\/fchem.2023.1145877","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:16:47Z","timestamp":1685060207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Single point mutations at the S129 residue of \u03b1-synuclein and their effect on structure, aggregation, and neurotoxicity"],"prefix":"10.3389","volume":"11","author":[{"given":"Esha","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lopamudra","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoy Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Dolui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumen","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joydeep","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhas C.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakul C.","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e26255","DOI":"10.4161\/idp.26255","article-title":"Biophysical characterization of \u03b1-synuclein and its controversial structure. Intrinsically Disord","volume":"1","author":"Alderson","year":"2013","journal-title":"Proteins"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease *","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2628","DOI":"10.1002\/brb3.2628","article-title":"Modeling Parkinson\u2019s disease-related symptoms in alpha-synuclein overexpressing mice","volume":"12","author":"Aniszewska","year":"2022","journal-title":"Brain Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of \u03b1-synuclein oligomers: Characterization by Raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1752-153x-7-91","article-title":"Potent anticancer activity of cystine-based dipeptides and their interaction with serum albumins","volume":"7","author":"Banerji","year":"2013","journal-title":"Chem. Cent. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/jpd-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2022","journal-title":"J. Park. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell Biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.jpcb.6b12332","article-title":"Stereoisomers probe steric zippers in amyloid-\u03b2","volume":"121","author":"Chandra","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/s0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Engl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1074\/jbc.m117.813865","article-title":"The small heat shock protein Hsp27 binds \u03b1-synuclein fibrils, preventing elongation and cytotoxicity","volume":"293","author":"Cox","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e89781","DOI":"10.1371\/journal.pone.0089781","article-title":"Sequence complexity of amyloidogenic regions in intrinsically disordered human proteins","volume":"9","author":"Das","year":"2014","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/acs.jpcb.9b09139","article-title":"Order, disorder, and reorder state of lysozyme: Aggregation mechanism by Raman spectroscopy","volume":"124","author":"Dolui","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1073\/pnas.1604645113","article-title":"Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation","volume":"113","author":"Flagmeier","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1074\/jbc.m117.812388","article-title":"Structural features of \u03b1-synuclein amyloid fibrils revealed by Raman spectroscopy","volume":"293","author":"Flynn","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0%3A571","article-title":"\u201cProtein identification and analysis tools on the ExPASy server,\u201d in the proteomics protocols handbook","volume":"22","author":"Gasteiger","year":"2005","journal-title":"J. M. Walk. (Humana Press)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2109617119","DOI":"10.1073\/pnas.2109617119","article-title":"\u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s12035-013-8406-x","article-title":"Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy","volume":"47","author":"Gon\u00e7alves","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14721","article-title":"Effects of alpha-synuclein post-translational modifications on metal binding","volume":"150","author":"Gonz\u00e1lez","year":"2019","journal-title":"J. Neurochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2019.00216","article-title":"Alpha-synuclein continues to enhance SNARE-dependent vesicle docking at exorbitant concentrations. Front","volume":"13","author":"Hawk","year":"2019","journal-title":"Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0217801","DOI":"10.1371\/journal.pone.0217801","article-title":"The interaction of several herbal extracts with \u03b1-synuclein: Fibril formation and surface plasmon resonance analysis","volume":"14","author":"Honarmand","year":"2019","journal-title":"PLOS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fnins.2019.01124","article-title":"Different heat shock proteins bind \u03b1-synuclein with distinct mechanisms and synergistically prevent its amyloid aggregation","volume":"13","author":"Jia","year":"2019","journal-title":"Front. Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.bbrc.2004.09.208","article-title":"\u03b1-Synuclein has structural and functional similarities to small heat shock proteins","volume":"324","author":"Kim","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1039\/c5an00342c","article-title":"Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: A review","volume":"140","author":"Kurouski","year":"2015","journal-title":"Analyst"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: Dissimilar incorporation of alpha-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1004741","DOI":"10.1371\/journal.pgen.1004741","article-title":"Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation","volume":"10","author":"L\u00e1zaro","year":"2014","journal-title":"PLOS Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41467-020-14831-x","article-title":"Elucidating heterogeneous photocatalytic superiority of microporous porphyrin organic cage","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/bi501188a","article-title":"Purification of \u03b1-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity","volume":"54","author":"Luth","year":"2015","journal-title":"Biochemistry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"11052","DOI":"10.1039\/c9cc04251b","article-title":"An aminoglycoside antibiotic inhibits both lipid-induced and solution-phase fibrillation of \u03b1-synuclein in vitro","volume":"55","author":"Mahapatra","year":"2019","journal-title":"Chem. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1021\/ja0356176","article-title":"Raman spectroscopic characterization of secondary structure in natively unfolded Proteins: \u03b1-synuclein","volume":"126","author":"Maiti","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ijbiomac.2020.03.238","article-title":"The status of the terminal regions of \u03b1-synuclein in different forms of aggregates during fibrillization","volume":"155","author":"Marvian","year":"2020","journal-title":"J. Biol. Macromol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/nen.0b013e3181a24b53","article-title":"\u03b1-Synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","article-title":"TorsinA and heat shock proteins act as molecular chaperones: Suppression of alpha-synuclein aggregation","volume":"83","author":"McLean","year":"2002","journal-title":"J. Neurochem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"key":"B44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson\u2019s disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/jpd-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: What have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Park. Dis."},{"key":"B46","first-page":"47","article-title":"Statistical insight into the binding regions in disordered human proteome","volume":"7","author":"Pal","year":"","journal-title":"J. Proteins Proteomics"},{"key":"B47","first-page":"259","article-title":"Origin of protein aggregation: Identification of some characteristic traits in structured and intrinsically disordered proteins","volume":"7","author":"Pal","year":"","journal-title":"J. Proteins Proteomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/hmg\/ddy326","article-title":"Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein","volume":"28","author":"Pinho","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B49","first-page":"90","article-title":"Identifying disordered regions in proteins from amino acid sequence","author":"Romero","year":"1997"},{"key":"B50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1074\/mcp.r113.032730","article-title":"Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies","volume":"12","author":"Schmid","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","article-title":"Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.1002\/chem.200902968","article-title":"Identifying the bond responsible for the fluorescence modulation in an amyloid fibril sensor","volume":"16","author":"Srivastava","year":"2010","journal-title":"Eur. J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41467-020-16564-3","article-title":"Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity","volume":"11","author":"Stephens","year":"2020","journal-title":"Nat. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1021\/jp070590o","article-title":"Computational study of thioflavin T torsional relaxation in the excited state","volume":"111","author":"Stsiapura","year":"2007","journal-title":"J. Phys. Chem. A"},{"key":"B57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0304-3940(02)01258-2","article-title":"Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila","volume":"336","author":"Takahashi","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/s0006-3495(01)76183-8","article-title":"Mechanisms of tryptophan fluorescence shifts in proteins","volume":"80","author":"Vivian","year":"2001","journal-title":"Biophys. J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1023\/b:japs.0000016303.37573.7e","article-title":"Spectral properties of thioflavin T and its complexes with amyloid fibrils","volume":"70","author":"Voropai","year":"2003","journal-title":"J. Appl. Spectrosc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/cells7120258","article-title":"Alpha-synuclein and calpains disrupt SNARE-mediated synaptic vesicle fusion during manganese exposure in SH-SY5Y cells","volume":"7","author":"Wang","year":"2018","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chroma.2016.11.005","article-title":"Alpha-synuclein in Parkinson\u2019s disease: From pathogenetic dysfunction to potential clinical application. Park","volume":"1720621","author":"Xu","year":"2016","journal-title":"Dis."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00381","article-title":"The roles of post-translational modifications on \u03b1-synuclein in the pathogenesis of Parkinson\u2019s diseases","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2023.1145877\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:50:10Z","timestamp":1780498210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2023.1145877\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":64,"alternative-id":["10.3389\/fchem.2023.1145877"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2023.1145877","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"article-number":"1145877"}}